THE SPECIFICITIES OF THE COMUTAGENESIS PHENOMENON FORMATION IN THE IRRADIATED CELLS OF CANCER PATIENTS
DOI:
https://doi.org/10.32471/oncology.2663-7928.t-23-4-2021-g.9979Keywords:
cancer patients, chromosome aberrations, comutagens, irradiated lymphocytes, microsatellite instabilityAbstract
Aim: to determine the specificities of formation of radiation-induced chromosome aberrations in human peripheral blood lymphocytes under conditions of comutagenesis (in vitro studies). Object and methods: the cytogenetic study was carried out on peripheral blood T-lymphocytes of 24 primary gynecologic cancer patients (study group) and 67 conditionally healthy subjects (comparison group). Isolation and cultivation of peripheral blood lymphocytes and metaphase analysis of radiation-induced chromosome aberrations was performed according to the standard protocol. Comutagens were introduced into the cell culture immediately after X-irradiation in therapeutic concentrations: verapamil — 1.0 μg/ml blood, ascorbic acid — 20.0 μg/ml blood, as well as in concentrations exceeding their values. Polymerase chain reaction (PCR) method was used to study microsatellite DNA instability of blood lymphocytes; Immunocytochemical method was used to study the process of apoptosis. Statistical methods were used. Results: ascorbic acid and verapamil in the therapeutic concentration did not affect the initial level of aberrations of chromosomes in non-irradiated lymphocytes of oncological patients. With the increase of verapamil concentration up to 4.0 μg/ml the frequency of chromosomal rearrangements in blood lymphocytes of cancer patients increased by 20.0%. By means of immunocytochemical analysis, we established that under irradiation with low doses (0.3 Gy) and additional action of verapamil (1.0 and 4.0 μg/ml blood) on lymphocytes of patients the highest number of caspase-3-positive nuclei in these cells is observed under the action of comutagen at 1.0 μg/ml. Under irradiation of lymphocyte culture at low doses (0.3 Gy) and under the additional action of ascorbic acid (20.0 and 80.0 μg/ml) the comutagenic effect — increase of aberration frequency by 1.7–1.4 times in comparison with radiation effect (19.0 ± 0.5 and 15.0 ± 0.7 vs 11.0 ± 0.4) was found. For the first time was detected DNA microsatellite instability due to comutagenic action of ascorbic acid on blood lymphocytes of irradiated in low dose patients. This fact could indicate the disturbance of misfolded nucleotides repair system in cells of circulating blood pools of patients. Conclusions: in irradiation (0.3 Gy) of blood lymphocytes of oncological patients, ascorbic acid exhibits comutagenic properties in a therapeutic concentration (20 μg/ml), and verapamil — at an increased concentration (4.0 μg/ml of blood). The increase in ascorbic acid (20.0; 40.0; 80.0 μg/ml) and verapamil (1.0; 1.5; 2.0 and 4.0 μg/ml) had stimulating effect on mitotic activity of irradiated lymphocytes of cancer patients. It was established for the first time that in the mechanisms of formation of comutagenic effects of ascorbic acid in the irradiated blood lymphocytes an important role is played by the disturbances of the system of reparation of wrongly paired nucleotides, causing changes in the DNA structural organization (microsatellite instability). The phenomenon of comutagenesis that develops in the irradiated lymphocytes of cancer patients is based on the processes of chromosomal and microsatellite instability, apoptosis and stimulation of cell proliferation.
References
Domina EA. Radiogenic cancer: Epidemiology and primary prevention. Kyiv: Naukova dumka, 2016. 196 p (in Russian).
Domina EA, Pylypchuk OP, Mikhailenko VM. Destabilization of human cell genome under the combined effect of radiation and ascorbic acid. Exp Oncol 2014; 36 (4): 236–40.
Domina EA, Pylypchuk OP, Mikhailenko VM. The modifying effect of co-mutagens on the frequency and spectrum of radiation-induced chromosome aberrations in human cells. Pharm Anal Acta 2015; 6: 377.
Morgan WF, Sowa MB. Non-targeted effects induced by ionizing radiation: mechanisms and potential impact on radiation induced health effects. Cancer Lett 2015; 356 (1):17–21.
Durnev AD, Seredenin SB. Co-mutagenesis as new vistas in genotoxicology. Bull Exp Biol Med.2003; 135 (6): 513–20.
Durnev AD, Daugel-Dauge NO, Zhanataev AK, et al. Comutagenic effects of valocordin. Ecol Genet 2012; 10 (3): 53–8 (in Russian).
Ashraf AA, Shakoori AR. Cytotoxic and genotoxic effects of arsenic on primary human breast cancer cell lines. Pakistan J Zool 2015; 47 (1): 79–87.
Grujicic D, Milosevic-Djordjevic O, Arsenijevic S, Marinković D. Treatment of pregnant women with a beta mimetic and verapamil increases the micronuclei frequency in umbilical cord blood lym phocytes. Tohoku J Exp Med 2008; 215 (4): 363–71.
Ashmawy IM, Nahas AF., Bayad AE. Teratogenic and cytogenetic effects of ivermectin and its interaction with P-glycoprotein inhibitor. Res Vet Sci 2011; 90 (1): 116–23.
Konopacka M. Rogolinski J. Clastogenic effects in human lymphocytes exposed to low and high dose rate X-ray irradiation and vitamin C. Nukleonika 2011; 56 (4): 253–7.
Demina EA, Pilinskaya MA, Petunin YuI, et al. Radiation cytogenetics: Russian-English dictionary-reference book. Kyiv: Zdorov’ya, 2009. 386 p (in Russian).
Sevankaev AV, Parshin VS, Mikhailova GF, et al. Comparative analysis of cytogenetic parameters with the morpho-functional state of the thyroid gland in children and adolescents living since the accident at the Chernobyl nuclear power plant in the territories of the Oryol and Kaluga regions contaminated with radionuclides. Radiat Risk 2006; 15 (1–2): 134–45 (in Russian).
Hagmar L, Strömberg U, Bonassi S, et al. Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts. Cancer Res 2004; 64 (6): 2258–63.
Joyner MS, Kogel O. Fundamentals of clinical radiobiology. Moscow: Binom. 2013. 600 р (in Russian).
Cytogenetic Dosimetry: Applications in Preparedness for and Response to Radiation Emergencies. Vienna: IAEA, 2011. 232 p.
Thompson SL, Compton DA. Chromosomes and cancer cells. Chromosome Res 2011; (19): 433–44.
Mazurkevich TA, Akseninko AV. Apoptosis and its mechanisms (review). Scientific works of the Southern branch of the National University of Life and Environmental Sciences of Ukraine 2013; (155): 309–16 (in Ukrainian).
Sinicrope FA, Sargent DJ. Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications. Clin Cancer Res 2012; 18 (6): 1506–12.
